Clinical Evaluation of the QuantiFERON CMV Assay

  • Observational
  • Recruiting
  • NCT03502161
Eligibility Details Visit Clinicaltrials.gov

Clinical Evaluation of the QuantiFERON CMV Assay

Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.

Gender
All

Age Group
18 Years and up

Accepting Healthy Volunteers?
No

Inclusion Criteria:

         - Adult CMV D+/R- liver, kidney, heart, pancreas, lung, intestinal, or combined transplant recipients that are 18 years of age or older.

         - Scheduled to receive between 3 to 6 months of antiviral prophylaxis

         - Provide Informed Consent

        Exclusion Criteria:

         - Subjects less than 18 years old

         - Scheduled to receive longer than 6 months or shorter than 3 months of prophylaxis

         - Unable to provide Informed Consent

At a Glance

National Government IDNCT03502161

IRB#IRB18-0989

Lead SponsorQIAGEN Gaithersburg, Inc

Lead PhysicianKathleen Mullane

Collaborator(s)N/A

EligibilityAll
18 Years and up
Recruiting